This story was first published in digitalhealth.net

The Department of Health and Social Care has announced that it will be committing over £30 million of funding to the global fight against antimicrobial resistance.
It is estimated that 5,000 deaths are caused every year in the UK because antibiotics no longer work for some infections, with antimicrobial resistance occurring when microbes, including bacteria, viruses, fungi and parasites, no longer respond to the drugs that would normally kill them.
Delivered through four new projects as part of the Global AMR Innovation Fund, the projects will be funded by UK aid and will primarily benefit people in low- and middle-income countries, where the burden of infection is greatest.
The funding includes £20 million to the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator – a non-profit international partnership supporting research on the most dangerous drug-resistant bacteria, as well as £5 million invested in the Foundation for Innovative New Diagnostics (FIND) – a global non-profit organisation aimed at the development, evaluation and delivery of high-quality affordable diagnostic tests for poverty-related diseases.
A further £5 million will be invested in a new bilateral partnership with Argentina supporting research to tackle AMR in agriculture and the impact on the environment, while £1 million will be invested in the Global Antibiotic Research and Development Partnership (GARDP) – a non-profit research and development initiative addressing global public health needs by developing, delivering and assuring sustainable access of new or improved antibiotic treatments.
Professor Dame Sally Davies, England’s Chief Medical Officer, said: “Today’s announcement is further evidence of the UK collaborating with international partners to lead global efforts to tackle AMR. The GAMRIF investments aim to protect the world’s most vulnerable and tackle AMR where the burden of infection is greatest. I am pleased that the UK will be working in partnership with a range of leading organisations to deliver vital research activities across the OneHealth spectrum – together this represents a formidable force against the threat of superbugs.”
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly